NanoEcho AB operates as a medical technology company. The company is developing a new diagnostic method to track rectal cancer's effect on nearby lymph nodes for the generation of health economic gains. Its imaging technology is based on a new medical method where nanotechnology is combined with modern ultrasound technology to improve diagnosis methods. The company was founded by Thomas Jannson on October 25, 2013 and is headquartered in Lund, Sweden.